[Translation] A single-center, randomized, open-label, single-dose, two-formulation, two-period, crossover study to evaluate the bioequivalence of calcium dobesilate dispersible tablets in healthy subjects
以海南林恒制药股份有限公司生产的羟苯磺酸钙分散片作为受试制剂,OM pharma S.A.生产的羟苯磺酸钙片(商品名:Doxium ,规格:250mg/片)为参比制剂,评估两种制剂空腹和餐后给药的生物等效性。
[Translation] Calcium dobesilate dispersible tablets produced by Hainan Linheng Pharmaceutical Co., Ltd. were used as the test preparation, and calcium dobesilate tablets (trade name: Doxium, specification: 250 mg/tablet) produced by OM pharma S.A. were used as the reference preparation to evaluate the bioequivalence of the two preparations when administered on an empty stomach or after a meal.